SEC Form 5 · accession 0001387131-15-000594
Adamis Pharmaceuticals Corp · ADMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Dennis J Carlo Ph.D.
Officer — President & CEO · Director
Period of report
Dec 31, 2014
Accepted (ET)
Feb 17, 2015 · 5:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000887247
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 27, 2014 | G | 20,000 | $0.00 | D | 418,219 | D | |
| Common Stock | Feb 27, 2014 | G | 4,119 | $0.00 | D | 418,219 | D |
Table II — derivative securities
No Table II lines on this filing.